Senté

Kleanthis Xanthopoulos did not come up through the cosmetics aisle. Before turning to topical skin repair, the molecular biologist had spent years running and building life-science ventures, including drug-discovery work tied to genomics and regenerative medicine, the kind of background that treats the skin as a biological system to be coaxed rather than a surface to be coated. He launched the company alongside fellow co-founder Marios Fotiadis, and the lab pedigree shaped everything that followed.

The central engineering problem was delivery. Heparan sulfate is a glycosaminoglycan the skin uses to manage inflammation and signal repair, but in its native form the molecule is far too large and unstable to pass through the stratum corneum. The team's work centered on shrinking and modifying it into a low-molecular-weight analog that could actually penetrate and stay active in a cosmetic base. That single modification is the brand's reason to exist, and it has since been extended into a second glycosaminoglycan platform built around dermatan sulfate and chondroitin sulfate, marketed under the DECO name, aimed at the same repair-and-resilience pathways.

The product strategy reflects the science. Rather than chase a sprawling catalog, the line pairs the proprietary analogs with established workhorses, retinol for renewal, cysteamine and other tone-correctors for stubborn discoloration, so the headline molecule never has to carry a formula alone. Distribution leaned for years on aesthetic practices and dermatology offices, where a clinical pitch lands better than a shelf does.

The market context is worth naming. "Regenerative" has become one of the most abused words in beauty marketing, slapped on serums whose only innovation is a trademarked filler name. What distinguishes this company is that the regenerative claim rests on a patented, genuinely novel molecule rather than a renamed commodity. The honest caveat is that much of the supporting data is generated in-house, and barrier-and-tone support is a gradual benefit, not a dramatic one, but the underlying chemistry is real, and rare.

Sources:[1][2][3]